It can be said that the major news that cancer has been conquered is closely related to the life and health of all mankind, and in this case, the overseas media naturally carried out a relatively large-scale report after learning about it.

I hope that my country can introduce this technology and completely solve the problem of difficult cancer treatment.

Many overseas netizens are also discussing on commonly used platform websites, and the popularity is no lower than that in China.

Because of the name of Deepin Technology, plus the videos released by Feng Wanqin and other patients who participated in the trial, they were also reprinted and uploaded on the website, so that most people did not doubt the authenticity of this technology, on the contrary, they wished that the technology could be introduced as soon as possible.

After all, according to the World Health Organization, there are more than 10 million cancer patients worldwide.

It is not known how many people die of cancer each year.

If cancer can be cured, it will be a huge advance in medicine for the entire human civilization.

But if you want to say that the biggest reaction, it must be the major pharmaceutical companies that made their fortune by researching anti-cancer drugs.

It is precisely because cancer has never been overcome that they need to continue to develop new anti-cancer drugs, which is also the guarantee of their company's profits.

Now that Deepin Technology has developed a new chimeric antigen receptor T-cell immunotherapy and announced a cure for cancer, it is conceivable how sluggish the market for anti-cancer drugs will be in the future.

This is bound to have a very big impact on them.

Pfizer is a world-renowned pharmaceutical company that occupies most of the global anti-cancer drug market.

That's when the losses will also be greatest.

Therefore, as the CEO, after receiving the news, Aibole made a decision without any hesitation and first discussed with other pharmaceutical companies to deal with follow-up measures.

Of course, in addition to them, there are also many international organizations that are interested in the research results of Deepin Technology.

……

WHO headquarters building, Switzerland's second largest city, 10 June 2024.

In the office with a flag planted diagonally behind him, the director-general, Thann Ced, is busy at his desk, dealing with tuberculosis and malaria and other diseases around the world.

As the world's largest health organization, its mission is to enable the world's people to achieve the highest possible level of health and to promote the prevention and treatment of epidemics and endemic diseases.

As the saying goes, the higher the level, the greater the responsibility, and it is a difficult and major problem to solve so many diseases around the world.

Just then, a knock on the door outside caught his attention, and he immediately raised his gaze.

"Please come in."

The next second, the door opened from the outside, and a middle-aged man with a sub-faceted face walked in.

Tan Said obviously knew the other party, and stood up to say hello without waiting for the other party to walk to the desk.

"My old friend, I haven't seen you in a few days."

Listening to Tan Said's words, Bei Luming, who is currently a member of the executive committee, immediately responded: "I came here this time to have very good news to tell you. He didn't hide the joy on his face when he spoke.

"Oh."

"I wonder what kind of good news it is?"

Tan Said was intrigued by Bei Luming's words, and asked casually.

In addition to being a member of the executive committee, Bei Luming is also a researcher in medicine, and is an authoritative technical expert and professor in the field of health.

To be able to call him good news is definitely not ordinary.

Bei Luming did not delay in this, and then told the other party the good news he knew.

"According to the latest news, the biological research laboratory of Deepin Technology has developed a new chimeric antigen receptor T cell immunotherapy, and they say that this technology can cure all kinds of cancer."

Yes.

The good news in Beiluming's mouth is that Deepin Technology has developed a new chimeric antigen receptor T cell immunotherapy.

After all, it is indeed great news that it is related to the fight against cancer.

It may be that he was busy dealing with the work summarized by various regions, Tan Said didn't know about the new project of Deepin Technology, and after hearing what Bei Luming said, his eyes suddenly widened and his expression was full of disbelief.

"What you said is true?"

"Can it really cure all kinds of cancer?"

He is naturally chimeric antigen receptor T-cell immunotherapy and has also been specifically aware of it before.

But even the most advanced technical team cannot cure cancer patients, let alone all kinds of cancer.

With this relationship, his first reaction was not to believe it.

However, this idea did not stay in his heart for long, and he decisively abolished it.

Very simple.

He knows very well that Bei Luming is a person, and the other party will definitely not talk nonsense about this kind of matter related to the health of human beings around the world, and since he has raised this matter, it has a high degree of authenticity.

Although it does make it hard to accept.

I just thought that if this was the case, nearly 20 million cancer patients around the world would benefit from it, and the number of diagnoses would drop significantly by next year.

At that time, the pressure on their organization will be much less.

The thought stayed here, and he couldn't hold back the excitement in his heart and asked as quickly as possible.

Bei Luming's mood is obviously similar to Tan Saide's, and when he hears this, he dares to delay for half a minute.

Speak up immediately about what you have.

"With the reputation of Deepin Technology in the world, it should not rashly release false news to affect the image, and this matter has also been confirmed by the official opposite."

"From the mouths of many cancer patients who have participated in the trial, it can also be seen that this new technology does have a strong effect."

"In addition, there is another special news, some people say that Xu Yun, who is known as the youngest genius of mankind, also participated in the research."

When Bei Luming said this, he paused for a moment to leave time for Tan Saide to think, and then expressed his opinion on this matter.

"In fact, regardless of whether this new technology can cure cancer, even if it has a certain effect, it is a major progress."

"You're absolutely right." Tan Said nodded to Bei Luming, as if he had made a decision, and said thoughtfully: "Our human struggle with cancer has lasted too long and too long, and if we can determine significant results this time, it will be a great victory in the history of medicine." ”

Almost as the last sentence fell, Tan Said arranged the follow-up itinerary very solemnly.

"It seems that we need to go and see what this technology is really like."

"I'll go get ready." Bei Luming nodded in agreement.

In any case, they haven't seen what this new technology actually looks like.

Even if it is to be promoted globally, it needs to be investigated first, after all, it is related to nearly 20 million cancer patients, and there must be no sloppiness.

Otherwise, if cancer patients in various regions are really called on to use this technology, the matter will be big if there is an emergency.

……

……

And just when the overseas forces are taking action, the Jingzhou side is extremely busy.

Although Jingzhou Hospital issued a statement in advance, saying that there is no way to accept more cancer patients, it still cannot avoid being full.

In this case, the hospital had to transfer personnel from other departments to collect blood for patients and send it to the biological research laboratory.

Even the first hospital in the back has reduced the intake of patients with other diseases and diverted them to other hospitals.

Such a lively and huge scene, to say that it is not an exaggeration, I am afraid it is the first time since the establishment of the hospital.

"Dr. Lin, the blood of these cancer patients has been processed, and we will send it to the biological research laboratory." The two general doctors in the department reported the situation to Lin Yi, obviously they had been busy and did not stop to rest, but no one complained about anything.

Lin Yi, who is temporarily in charge of this task, of course understands everyone's hard work.

After responding, he didn't forget to say two words of relief.

"Pay attention to safety on the road, and when the new department in our hospital is ready, we can save a lot of trouble."

"Seeing so many cancer patients being treated doesn't feel tired." In the face of Lin Yi's words, one of the young doctors said with a smile, judging from the expression he revealed, it was obviously from the heart.

"Doctor Nalin, we're over."

He spoke again, and the two of them turned to leave.

Lin Yi looked at the backs of the two of them until the figures completely disappeared from view, and then he withdrew his gaze and looked at the information on the desktop.

It has been less than two weeks since the launch of the new chimeric antigen receptor T-cell immunotherapy, and the first batch of patients who have been injected with customized injections have improved significantly after examination.

The number of cancer cells in the body drops dramatically in an instant.

This makes the patient, who was still a little scared, completely let go of the new one.

At the same time, there are more treatment groups, and the powerful therapeutic effect of this technology can be proved to be even more crazy for cancer patients who have not yet received treatment.

Some patients who are quite wealthy do not hesitate to spend a lot of money to get priority treatment places.

It's a pity that at present, only biological research laboratories have therapeutic capabilities, and in order to ensure efficiency, the whole process is also connected to the artificial intelligence of deep technology.

It is unlikely that there will be a place to buy a place.

We can only control the condition with routine treatment first, while waiting for more hospitals to open new departments.

As Lin Yi said just now, in order to ensure that cancer patients can receive new technology treatment, the first batch of key hospitals will be supported to set up new departments.

This new department will have an environment for cell modification and expansion, which will be dedicated to the treatment of cancer patients in the future.

When these departments are officially opened to the public, the pressure on Jingzhou will be reduced a lot in an instant.

Meanwhile.

In the biological research laboratory of Longfor Science and Technology Park, Xu Yun, who was wearing a research coat, was busy in the operation room.

Although he does not need to participate in his own capacity, after all, the transformation and expansion of cells have been processed, and even a newly arrived doctoral researcher assistant can be responsible, but because the number of cell copies to be carried out every day during this time is too much, he has to do it himself under the shortage of laboratory personnel.

I even have to work overtime every day to go home to spend time with my family.

But there is no way to do it, after all, working more will make it possible to treat one more cancer patient.

Save a family.

Just as he was waiting for the blood samples of the new patient to be sent, Ding Wei found Xu Yun in the gap.

"I have something to discuss with you, Dean Li of the Academy of Engineering said that he would come to the laboratory today, accompanied by WHO Director-General Tan Said, and Ms. Sperge, editor-in-chief of Nature Magazine."

Listening to the news that Ding Wei said, Xu Yun couldn't help but raise his eyes to make himself more serious.

Dean Li of the Academy of Engineering naturally knew about it, and it was not inappropriate to come to the laboratory to see the situation.

As the world's top scientific journal, nature will definitely be very interested in overcoming such a major research topic as cancer, and they want to understand the situation and report it to the outside world.

However, it was a surprise that it had attracted the attention of international organizations so quickly, and that the Director-General had come in person.

All people are equal when it comes to cancer, and he certainly doesn't mind making this technology available on a global scale to cure more cancer patients if he has the opportunity.

Of course, the premise is that overseas regions are willing to accept the technology license and introduce the technology in the past.

Otherwise, for those overseas patients, I am afraid that they will have to go to Jingzhou for treatment.

The thought stayed here, Xu Yun thought for a while and said, "Then you can take the time to introduce the situation to them in the afternoon." ”

But Ding Wei didn't gladly accept this, but shook his head and said: "They are all coming for you in Xu Yuan, what's the matter if I stand up, doesn't it make everyone unhappy." Apparently he had already thought about what he had planned for the matter.

It is true that he is the initiator of the laboratory chimeric antigen receptor T cell immunotherapy project, but Xu Yun is the one who makes the technology upgrade, and he will not take this credit.

In the face of Ding Wei's answer, Xu Yun could also understand the thoughts in the other party's heart.

Although I didn't like this kind of occasion very much, I thought of the positive impact that the WHO and Nature could bring, and finally had to agree.

"I see, I'll receive them then."

"Then I'll be relieved." Ding Wei took Xu Yun's words and responded.

——

I have to say that Li Houlin and his entourage are indeed in a hurry, and they have arrived at Jingzhou Longhu Science and Technology Park shortly after eating in the afternoon.

Because he had greeted him in advance in the morning, Xu Yun brought someone over to greet him after he got the news.

"Dean Li, you are welcome to guide the work."

Xu Yunying stepped forward and shook hands with Li Houlin while smiling and saying.

In this regard, Li Houlin hurriedly quipped: "Just come here today and treat us as students, I can't talk about guidance here with your academician Xu." ”

Obviously, he has a clear understanding of himself, and he has not exalted himself because of the identity of the dean.

After responding, he didn't wait for Xu Yun to say more, and took the initiative to introduce the people around him this time.

"Let me introduce you first."

"This is Mr. Chad Tan, the Director-General of the World Health Organization, and Professor Pei Luming, a member of the Executive Committee."

"Ms. Sperkey is the current editor-in-chief of Nature Magazine, and they are very interested in your lab's topic."

As Li Houlin finished introducing in turn, Xu Yun also stretched out his arm to shake hands and say hello.

Soon the atmosphere became familiar.

It is worth mentioning that although he has dealt with nature and science magazines before, this Ms. Sperkey is clearly the new editor-in-chief.

We haven't met before.

At this moment, Tan Said's attention was all on Xu Yun, taking the opportunity to take a closer look at this young man who was called the most talented scientist in mankind, if it weren't for Xu Yun's too many achievements, I am afraid that no one would be able to connect with the young man in front of him.

For the time being, he was holding back the excitement in his heart, until everyone officially entered the biological research laboratory, and Tan Said noticed the busy researchers around him, so he couldn't help but ask.

"Academician Xu."

"Can you tell us about your lab's latest chimeric antigen receptor T cell immunotherapy topic?"

Almost as soon as Race's words fell, Ms. Sperkey, the editor-in-chief of Nature Magazine, echoed him: "This topic is currently causing a huge discussion in the entire medical community, and we in Nature are ready to continue to pay attention to seeing cancer being conquered." ”

Bei Luming, a technical expert in the health field next to him, did not open his mouth in this situation, but his attention was always on Xu Yun's body.

Xu Yun understands that they are all here for the latest chimeric antigen receptor T-cell immunotherapy technology in the laboratory, and they will not deliberately sell off in this case.

Then he talked about it as he walked.

"I think everyone here is no stranger to chimeric antigen receptor T-cell immunotherapy."

"The use of this therapy allows for the customization of the treatment plan for the patient, and the result is to destroy the cancer cells by modifying the cells."

"However, this traditional therapy has a long cycle, and there are corresponding side effects and poor effects for patients, and our laboratory optimizes and upgrades the technology on this therapy."

"The new therapy we have obtained not only has a short cell modification expansion cycle, but also has no side effects for patients."

"In addition, in addition to the treatment effect of known cancers, the cost of treatment is only about one-tenth of the traditional one-third."

A few people who were quite calm just now, after listening to these technical advantages that Xu Yun said, it was difficult for the whole person to control the excitement in their hearts.

What concept does this represent.

According to Xu Yun's situation, if it is promoted globally, not only can the number of cancer patients be reduced to a very low level, but the key is that it will not cost too much money.

In recent years, due to the arrears of membership dues in many regions, the foundation funds of the organization are really not sufficient.

If the cost of this new treatment is also as high as several millions, it will be very troublesome to promote it in a short period of time, even if it has a good curative effect.

It will even be caught by those pharmaceutical companies to make a fuss in order to prevent the promotion of this technology.

Bei Luming is a technical expert in this field, and he himself has studied chimeric antigen receptor T cell immunity.

So he knows how difficult it is to improve efficiency, avoid side effects, and reduce the cost of treatment.

It is no exaggeration to say that coming up with one of them alone may require a long time of effort by the research team.

Otherwise, this technology will not be without breakthroughs for long.

But in this laboratory of Deepin Technology, the original difficulty seems to have been completely ignored, and it is so easy to upgrade the technology optimization to such an unbelievably amazing level.

This made him wonder what kind of special magic this laboratory had.

The thought stayed here, and the next second he seemed to think of something, and without waiting for Xu Yun to continue, he took advantage of the gap to ask.

"I wonder if there is any detailed data to support what you are talking about?"

Hearing this, Xu Yun turned to look at the executive committee member with a familiar face, and replied with a smile on the corner of his mouth and extremely confident: "I think those cancer patients we have successfully cured during this period will be the most powerful data support." ”

His words are not wrong at all, and at this point in the day, the new chimeric antigen receptor T-cell immunotherapy no longer needs any data to prove it.

Those who have been cured of cancer are the best illustration of this.

Speaking of which, Xu Yun continued to introduce, which can be regarded as letting them know the general process of this technology.

Not much.

When everyone returned to the lounge, it can be said that they have completely believed that the new chimeric antigen receptor T-cell immunotherapy can conquer cancer.

I only felt deeply shocked in my heart.

In fact, Tan Said still had some doubts in his heart before he came, afraid that it would be empty joy in the end.

But Xu Yun let him really know why the other party can be called the most talented young scientist in the history of mankind.

Even if all of Xu Yun's previous achievements are ignored, the development of a new chimeric antigen receptor T-cell immunotherapy technology alone is enough to be remembered forever by the history of human civilization.

At this time, Tan Saide finally made up his mind, and then set his eyes on Xu Yun and said very solemnly:

"Academician Xu."

"This new chimeric antigen receptor T-cell immunotherapy technology developed by you and your lab is truly great for all cancer patients around the world."

"This will effectively reduce the number of cancer patients worldwide."

"So on behalf of WHO, I want to get authorization to use this technology."

Xu Yun originally wanted to use this technology to treat more cancer patients, and there are international organizations willing to help with this, which can be said to be unbelievable.

So without any hesitation, he directly agreed: "Of course there is no problem." ”

After that, he added: "And in addition, other companies or hospitals can also come to buy technology licenses from us." "When I speak, I always smile and make people feel like a spring breeze.

"That's great, and I'll personally call for action in all parts of the world when I get back." Tan Said was very satisfied with Xu Yun's decision and immediately said that he would help at that time.

It is also worth mentioning that Ms. Sperkey, the editor-in-chief of Nature Magazine, also said that she will report on this topic in the latest issue.

It may be that what they saw and heard today stimulated them too much, and they originally wanted to stay in Jingzhou for dinner, but in the end, they all said that they would go back as soon as possible to carry out the corresponding work.

Xu Yun naturally couldn't stop him, so he had to invite them to come to Jingzhou as guests in the future.

However, Li Houlin only let the people below accompany him, and he himself temporarily stayed in Longhu Science and Technology Park.

When only his own people were left, Li Houlin finally became active, and his eyes looked at Xu Yun as satisfied as he wanted.

"I knew it would be okay with your talent, and now it turns out that my judgment is correct."

"You have only been in contact with the field of medicine and genetic engineering for a long time, and you have successfully optimized and upgraded Lao Ding's research projects for many years, which is something that no one else in the hospital can imagine."

"How about it, do you want to enter the engineering academy?"

At the dinner table, Li Houlin did not hide his purpose at all, and asked openly in front of others.

Since Xu Yun was elected as an academician of the Academy of Sciences, he felt envious every time he saw the results of a new project, and he insisted on letting the Academy of Sciences, which mainly engages in theory, suppress them.

It is no exaggeration to say that sometimes he dreams that he hopes that Xu Yun is a member of their engineering academy.

This time, Xu Yun took the initiative to get involved in medical genetic engineering, which made him finally see hope.

I want to find an opportunity for Xu Yun to also be elected as an academician of the Academy of Engineering.

Nowadays, the new chimeric antigen receptor T-cell immunotherapy has shaken the entire medical community around the world, and I don't know how many cancer patients can return to normal life, which is enough to be elected as an academician of the Academy of Engineering.

Today, he specially accompanied Tan Saide and Sperkey and others from the imperial capital, and another thing was to officially invite Xu Yun.

"Join the Academy of Engineering?"

suddenly brought the topic to this matter, Xu Yun was also unexpected, and couldn't help but be a little stunned.

He really hadn't thought about joining the Academy of Engineering before, and he didn't know how to answer for a while.

However, this reaction can make Li Houlin very worried, and he hurriedly opened his mouth to continue to persuade.

"There are two top research institutes, and there are more than 30 people who can win the honor of academicians of the two academies since the establishment of the institute."

"It's the first one at a young age like you."

Speaking of this, I didn't forget to glance at Ding Wei next to him, which means that your old boy is a member of the Engineering Institute, so don't hurry up to help at this time.

Ding Wei didn't know the meaning in Li Houlin's eyes, so he had to temporarily put down his chopsticks and interject.

"There are indeed very few academicians who can win the honor of academician of the Chinese Academy of Sciences and the Chinese Academy of Sciences, for example, I am only an academician of the Academy of Engineering until I retire, and it is really enviable to be honest with a young academician of the Chinese Academy of Sciences and the Chinese Academy of Sciences like you."

As for Professor Zhou Lihua opposite, she has always remained silent in the face of this situation, not saying a word.

After all, there is no way to do this, the lowest status in the audience is a second-level professor, and the others are an old academician and a dean, as well as the youngest academician of the two academies, and she really doesn't leave anyone with any way to live.

Thinking about it carefully, Xu Yun is not resistant to the Academy of Engineering, not to mention that some key projects still rely on the Academy of Engineering.

Besides, becoming an academician of the Chinese Academy of Sciences and the Chinese Academy of Sciences is also better to facilitate his research, so no matter what point of view, there is really no reason to refuse.

The thought stayed here, and Xu Yun had no choice but to nod and say, "Then do as Dean Li said." ”

"That's right, I'll have to talk to you Dean Hou when the time comes." After receiving Xu Yun's affirmative answer, Li Houlin was immediately relieved, and his face was full of bright smiles.

After eating, Li Houlin temporarily stayed in the arranged hotel, and returned to the imperial capital the next day.

And just when Tan Said and Sperge went back and started to act, Ruihui Biotech finally made a decision.

After discussions with other well-known pharmaceutical companies, they understood that with the launch of the new technology by Deepin Technology, it was impossible for the Asian side to successfully recover the anti-cancer drug market.

After all, it is the home of Deepin Technology.

In this case, they can only choose to break the wrist of a strong man and strive to keep the overseas anti-cancer drug market.

No matter what method is used.

Anti-cancer drugs occupy most of the company's business, and the losses caused by heavy losses are incalculable, so whether they succeed or not in the end must be tried.

——

"Let's implement the plan adopted at the meeting, and while we still have an advantage, we must continue to expand our advantage."

In the office of the CEO of the headquarters of Ruihui Biologics, Ai Bole commanded Paina in front of him with a calm face.

After experiencing the deep technology biological research laboratory, it can be said that nothing can cause him to make waves.

Originally, the new drug performed well, and it was a good time for the company to recover its R&D costs and make profits, but a new chimeric antigen receptor T-cell immunotherapy suddenly came out, and the key was to crush their anti-cancer drugs in all aspects.

It can be said that the head-to-head competition cannot be beaten at all.

No way.

Only some special measures can be taken.

"Deepin Technology will launch their technology at this time, I am afraid that it will not only meet part of the market, can our solution alone prevent them from entering the global market?"

Faced with her boss's orders, Payina did not immediately carry them out.

Instead, he spoke out about his worries.

The so-called plan adopted at the meeting is to convince everyone that the new technology of Deepin Technology is not reliable and does not have the effect of propaganda.

Coupled with the side effects that are much higher than the drug, it will naturally make people think carefully.

Although this method of splashing dirty water is quite low-level, it is practical as long as it works.

When the time comes, they just need to join forces to stop the technology from being introduced.

Then you can guarantee your own market.

What's more, they simply don't have any other way.

Whoever made the development of this technology was Deepin Technology.

Faced with Payina's concern, Ebola slowly raised his gaze and sighed before answering.

"You have to understand that our opponent this time is Deepin Technology, and that's all we can do at the moment."

"I know boss." Payina nodded in reply.

Although she still wanted to say something, she saw her boss's expression, and the words came to her mouth and swallowed them back.

Then he turned and walked out of the office.

Although the last negotiation in the imperial capital failed, it has to be said that Paina is still very efficient in doing things.

Almost on the same day, on several platforms with the largest number of overseas users, there were many voices questioning the new chimeric antigen receptor T cell immunotherapy of deep technology, including some professors and scholars with certain authority in the medical field.

Because the technology of Deepin Technology is too effective, it makes people feel unreal, and there are more and more questioning remarks, even people with some ideas will have self-doubt.

I don't know if I want to dispel my thoughts, but I still choose the traditional treatment plan.

But just when the bureau was developing on the side of pharmaceutical companies, Tan Ced suddenly held a press conference to announce that he would cooperate with Deepin Technology to use a new chimeric antigen receptor T cell immunotherapy for cancer diseases.

At the same time, at the press conference, the powerful effect of the new chimeric antigen receptor T cell immunity was highly affirmed, and all regions were called on to actively carry out friendly cooperation with in-depth science and technology.

Working together for the global eradication of cancer.

In addition, on the same day, Nature magazine released a new journal, which not only used the topic of the DeepTech Biological Research Laboratory as the cover, but also reported the research process of this technology.

Most importantly, Xu Yun's important role in this project was announced.

Let everyone know that Xu Yun, who is known as the most talented scientist in mankind, has not only stepped into a new field, but also created miracles to overcome cancer again, making an important step forward in the development of human medicine.

……

(End of chapter)